Wang Jianliu

Wang Jianliu is a clinical research and medical technology entity led by Professor Wang Jianliu, a renowned gynecological oncologist and the Party Secretary and Vice President of Peking University People's Hospital. The entity focuses on the development and clinical validation of innovative therapies and diagnostics for gynecological conditions, including endometrial and cervical cancers. It is particularly recognized for the "4R" clinical concept (Relieving tumors, Preserving organs, Remodeling functions, and Achieving childbirth), which has set national standards for fertility-preserving treatments. The group actively collaborates with biotechnology companies to lead multi-center clinical trials for novel agents such as selective androgen receptor modulators and non-invasive, urine-based HPV screening technologies.